Form D · Biotechnology

Neurvana Medical, LLC

Tustin, CA · CIK 0001719372

Offering snapshot reported Oct 23, 2017 · SEC filing

Reported sold
$3.24M
Offering amount: $5.5M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.62M$3.24MOct 23, 2017: $967,500.00Oct 23, 2017Oct 23, 2017: $3,243,434.00Oct 23, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$967,500 → $3,243,434
  • Reported investors3 → 19

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 23, 2017Amendment$3,243,434$2,275,934vs Oct 23, 201719SEC filing
Oct 23, 2017Initial$967,500No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-297234

Source: Form D, filed Oct 23, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Abrams Director
Kenneth Baker Director
David Ferrera Director
Thomas G. Fogarty Director, Executive
Jeffrey Goldberg Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3002 Dow Avenue, Suite 138
Tustin, CA, 92780